Health Catalyst
HCAT
159 hedge funds and large institutions have $500M invested in Health Catalyst in 2023 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 55 increasing their positions, 52 reducing their positions, and 14 closing their positions.
36% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 14
3% more funds holding
Funds holding: 154 → 159 (+5)
6% more repeat investments, than reductions
Existing positions increased: 55 | Existing positions reduced: 52
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.1% less ownership
Funds ownership: 86.78% → 86.68% (-0.1%)
18% less capital invested
Capital invested by funds: $610M → $500M (-$111M)
59% less call options, than puts
Call options by funds: $210K | Put options by funds: $507K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$17.7M |
| 2 |
Primecap Management
Pasadena,
California
|
+$6.2M |
| 3 |
Bank of New York Mellon
New York
|
+$5.65M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
+$4.65M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$3.29M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.43M |
| 2 |
KCM
Kingdon Capital Management
New York
|
-$6.51M |
| 3 |
Goldman Sachs
New York
|
-$4.4M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$3.87M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$3.24M |
HCAT Hedge Fund Activity: Q3 2023 in Review
159 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Health Catalyst (HCAT) for Q3 2023, worth a combined $500M — down 18% from $610M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new HCAT positions and 14 closed out — a net gain of 5 holders — while 55 added to existing stakes and 52 trimmed.
The largest buyer was Point72 Asset Management, adding an estimated $17.7M. The largest seller was Rock Springs Capital Management, cutting an estimated $7.43M.
- 159 institutional investors held Health Catalyst (HCAT) as of Q3 2023, up from 154 in Q2 2023.
- Funds reported $500M of Health Catalyst stock for Q3 2023, down 18% quarter-over-quarter.
- 19 funds opened new Health Catalyst positions in Q3 2023 and 14 closed out, a net change of +5 holders.
- The largest Health Catalyst buyer in Q3 2023 was Point72 Asset Management, an estimated $17.7M added.
- The largest Health Catalyst seller in Q3 2023 was Rock Springs Capital Management, an estimated $7.43M sold.
Based on aggregated 13F filings for Q3 2023.